Symposium 9: Beyond lifestyle changes. Pharmacological approach

Authors

  • Lidia Caracotche Argentine Society of Pediatrics, Autonomous City of Buenos Aires, Argentina

DOI:

https://doi.org/10.47196/diab.v56i3Sup.519

Keywords:

diabetes mellitus, drugs

Abstract

The prevalence of overweight and obesity in pediatrics has increased drastically in recent decades. This leads to a greater cardiometabolic, oncological, psychiatric burden and in the quality of life in adulthood. Data from the COVID 19 pandemic aggravated the incidence and prevalence of obesity due to changes in eating habits and sedentary lifestyle.

The objectives in pediatric treatment propose a reduction of 0.2 in the BMI z-score (5% decrease in BMI), with clinically significant results. The initial strategy is to optimize lifestyle intervention and reduce environmental exposures. However, there remains a subgroup of severely obese children and adolescents who do not respond to these changes, requiring the use of safe, effective and approved drugs for this age group. Currently only 3 pharmacological agents are approved for use in adolescents over 12 years of age and for more than 1 year of treatment, these are: orlistat, fentermine y liraglutide.

Author Biography

Lidia Caracotche, Argentine Society of Pediatrics, Autonomous City of Buenos Aires, Argentina

Diabetologist, specialist in Child Nutrition

References

I. Styne D, Arslanian S, et al. Pediatric obesity. Assessment, treatment, and prevention: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab March 2017;102(3):709-757.

II. González-Bagnesa MF, González C, et al. Pharmacotherapeutic options in pediatric obesity: an urgent call for further research. Expert Opinion on Pharmacotherapy 2022.

III. Ryan PM, et al. Safety and efficacy of glucagon-like peptide-1 receptor agonists in children and adolescents with obesity. J Pediatr 2021;236:137-147.

IV. Kelly AS, et al. A randomized, controlled trial of liraglutide for adolescents with obesity. N Engl J Med 2020;382:2117-2128.

Published

2022-09-01

How to Cite

Caracotche, L. (2022). Symposium 9: Beyond lifestyle changes. Pharmacological approach. Journal of the Argentine Society of Diabetes, 56(3Sup), 28–28. https://doi.org/10.47196/diab.v56i3Sup.519

Most read articles by the same author(s)